Cause of death, by non-communicable diseases, ages 0-4, female in Sweden
Sweden: Cause of death, by non-communicable diseases, ages 0-4, female was 46.6% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 0-4, female in Sweden, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in Sweden stood at 46.6%.
That represents a change of up 4.6% on the previous year and down 6.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Sweden peaked at 55.6% in 2000 and was at its lowest, 41.3%, in 2015.
Sweden ranks 18th of 185 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 0-4, female in Sweden, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 55.6% | — |
| 2010 | 49.7% | -10.8% |
| 2015 | 41.3% | -16.8% |
| 2019 | 47.9% | +16.0% |
| 2020 | 44.6% | -7.0% |
| 2021 | 46.6% | +4.6% |
Sweden compared with similar countries
- Sweden's 46.6% is above the median for high income countries, which is 42.8%, 1.1× the median. (58 countries reporting)
- Sweden's 46.6% is above the median for Europe & Central Asia, which is 39.9%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 55.6% | 55.6% | 55.6% | 1 |
| 2010s | 46.3% | 41.3% | 49.7% | 3 |
| 2020s | 45.6% | 44.6% | 46.6% | 2 |
Countries ranked near Sweden
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,109 deaths per 1,000 people (2090)
- Number of infants who die before age 1 30 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.12 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0243 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Sweden?
- Cause of death, by non-communicable diseases, ages 0-4, female in Sweden was 46.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Sweden?
- The highest recorded value was 55.6% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Sweden?
- The lowest recorded value was 41.3% in 2015.
- How does Sweden rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Sweden ranks 18th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Sweden?
- Over the last ten years it is down 6.1%. The long-run trend across the full record is falling.
- Where does this Sweden data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.